This document summarizes a presentation on sperm DNA fragmentation from the perspective of a male infertility specialist. It discusses the relationship between sperm DNA fragmentation and infertility, methods for assessing sperm DNA fragmentation, and strategies for managing elevated sperm DNA fragmentation levels. The key points are that sperm DNA fragmentation provides different and more prognostically useful information than a semen analysis, is mainly caused by oxidative stress during sperm transit through the epididymis, and is associated with infertility, poor assisted reproductive technology outcomes, and miscarriage.
Sperm DNA Fragmentation (Oxidative stress, DNA damage and apoptosis, Test, Techniques, Relation to other semen parameters, Relationship to leucocytes, Relation to ICSI outcomes, Clinical applications, significance and limitations)
Iran march 2011
ABRASCT:
SPERM RETRIEVAL TECHNIQUES FOR THE AZOOSPERMIC MALE
Sandro C. Esteves, MD, PhD
Spermatozoa can be retrieved from either the epididymis or the testis, depending on the type of azoospermia, using different surgical methods such as PESA, MESA, TESA, TESE and micro-TESE.
In obstructive azoospermia (OA), sperm production is normal and gametes can be easily retrieved from the epididymis or the testicle in most cases, irrespective of the technique. PESA or TESA are simple and efficient methods for retrieving epididymal or testicular spermatozoa in men with OA. According to our data on OA, the etiology of the obstruction and the use of fresh or frozen-thawed epididymal/testicular sperm do not seem to affect ICSI outcomes in terms of fertilization, pregnancy, or miscarriage rates.
In cases of nonobstructive azoospermia (NOA), the efficiency of TESA for retrieving spermatozoa is lower than TESE, except in the favorable cases of men with previous successful TESA or testicular histopathology showing hypospermatogenesis. The use of microsurgery during TESE may improve the efficacy of sperm extraction with significantly less tissue removed, which ultimately facilitates sperm processing. Testicular histology results, if available, may be useful to predict the chances to retrieve sperm in men with NOA. Our data demonstrate that micro-TESE performs better than conventional TESE or TESA in cases of maturation arrest and Sertoli cell-only histological patterns, where tubules containing active focus of spermatogenesis can be positively identified using microsurgery. Testicular spermatozoa can be obtained even in the worst case scenario except in the cases of Y chromosome infertility with complete AZFa and/or AZFbmicrodeletions.
In both OA and NOA, sperm retrieval technique itself seems to have no impact on ICSI success rates. The main goal of PESA/TESA/TESE sperm processing is the recovery of a clean sample containing motile sperm. Such specimens are more fragile, and often compromised in motility, as compared to the ones obtained from ejaculates. Laboratory techniques should be carried out with great caution not to jeopardize the sperm fertilizing potential. Surgically-retrieved spermatozoa can be intentionally cryopreserved for future use. Spare left-over specimens that would be discharged after ICSI can also be cryostored. Different strategies can be developed according to each group’s results. If freezing of surgically-retrieved specimens provides results similar to those with the use of fresh sperm, then the use of freezing specimens would be preferable. If not, fresh specimens are preferable.
The reproductive potential of infertile men undergoing ART is related to the type of azoospermia. According to our data, the chances of retrieving spermatozoa (odds ratio [OR] = 43.0; 95% confidence interval [CI]: 10.3-179.5) and of achieving a live birth by ICSI (OR=1.86; 95% CI:l 1.03-2.89) were significantly increased in couples whose male partner had obstructive rather than non-obstructive azoospermia. Children conceived using sperm retrieved from men with OA and NOA should be followed-up because it is still unclear if there is an increased risk of birth defects when ICSI is carried out with non-ejaculated sperm.
References
Esteves SC, Glina S. Recovery of spermatogenesis after microsurgical subinguinal varicocele repair in azoospermic men based on testicular histology. IntBraz J Urol. 2005; 31:541-8.
Verza S Jr, Esteves SC. Sperm defect severity rather than sperm source is associated with lower fertilization rates after intracytoplasmic sperm injection. IntBraz J Urol. 2008,34:49-56.
Esteves SC, Verza S, Prudencio C, Seol B. Sperm retrieval rates (SRR) in nonobstructive azoospermia (NOA) are related to testicular histopathology results but not to the etiology of azoospermia. FertilSteril. 2010; 94(Suppl.):S132.
Esteves SC, Verza S, Prudencio C, Seol B. Success of percutaneous sperm retrieval and i
Sperm DNA Fragmentation (Oxidative stress, DNA damage and apoptosis, Test, Techniques, Relation to other semen parameters, Relationship to leucocytes, Relation to ICSI outcomes, Clinical applications, significance and limitations)
Iran march 2011
ABRASCT:
SPERM RETRIEVAL TECHNIQUES FOR THE AZOOSPERMIC MALE
Sandro C. Esteves, MD, PhD
Spermatozoa can be retrieved from either the epididymis or the testis, depending on the type of azoospermia, using different surgical methods such as PESA, MESA, TESA, TESE and micro-TESE.
In obstructive azoospermia (OA), sperm production is normal and gametes can be easily retrieved from the epididymis or the testicle in most cases, irrespective of the technique. PESA or TESA are simple and efficient methods for retrieving epididymal or testicular spermatozoa in men with OA. According to our data on OA, the etiology of the obstruction and the use of fresh or frozen-thawed epididymal/testicular sperm do not seem to affect ICSI outcomes in terms of fertilization, pregnancy, or miscarriage rates.
In cases of nonobstructive azoospermia (NOA), the efficiency of TESA for retrieving spermatozoa is lower than TESE, except in the favorable cases of men with previous successful TESA or testicular histopathology showing hypospermatogenesis. The use of microsurgery during TESE may improve the efficacy of sperm extraction with significantly less tissue removed, which ultimately facilitates sperm processing. Testicular histology results, if available, may be useful to predict the chances to retrieve sperm in men with NOA. Our data demonstrate that micro-TESE performs better than conventional TESE or TESA in cases of maturation arrest and Sertoli cell-only histological patterns, where tubules containing active focus of spermatogenesis can be positively identified using microsurgery. Testicular spermatozoa can be obtained even in the worst case scenario except in the cases of Y chromosome infertility with complete AZFa and/or AZFbmicrodeletions.
In both OA and NOA, sperm retrieval technique itself seems to have no impact on ICSI success rates. The main goal of PESA/TESA/TESE sperm processing is the recovery of a clean sample containing motile sperm. Such specimens are more fragile, and often compromised in motility, as compared to the ones obtained from ejaculates. Laboratory techniques should be carried out with great caution not to jeopardize the sperm fertilizing potential. Surgically-retrieved spermatozoa can be intentionally cryopreserved for future use. Spare left-over specimens that would be discharged after ICSI can also be cryostored. Different strategies can be developed according to each group’s results. If freezing of surgically-retrieved specimens provides results similar to those with the use of fresh sperm, then the use of freezing specimens would be preferable. If not, fresh specimens are preferable.
The reproductive potential of infertile men undergoing ART is related to the type of azoospermia. According to our data, the chances of retrieving spermatozoa (odds ratio [OR] = 43.0; 95% confidence interval [CI]: 10.3-179.5) and of achieving a live birth by ICSI (OR=1.86; 95% CI:l 1.03-2.89) were significantly increased in couples whose male partner had obstructive rather than non-obstructive azoospermia. Children conceived using sperm retrieved from men with OA and NOA should be followed-up because it is still unclear if there is an increased risk of birth defects when ICSI is carried out with non-ejaculated sperm.
References
Esteves SC, Glina S. Recovery of spermatogenesis after microsurgical subinguinal varicocele repair in azoospermic men based on testicular histology. IntBraz J Urol. 2005; 31:541-8.
Verza S Jr, Esteves SC. Sperm defect severity rather than sperm source is associated with lower fertilization rates after intracytoplasmic sperm injection. IntBraz J Urol. 2008,34:49-56.
Esteves SC, Verza S, Prudencio C, Seol B. Sperm retrieval rates (SRR) in nonobstructive azoospermia (NOA) are related to testicular histopathology results but not to the etiology of azoospermia. FertilSteril. 2010; 94(Suppl.):S132.
Esteves SC, Verza S, Prudencio C, Seol B. Success of percutaneous sperm retrieval and i
ICSI as it is presently performed is far from an ideal solution because the selection of sperm is based on the judgement of an embryologist, who is looking for the most normal appearing sperm available.
the objective is to clarify the problem of recurrent implantation failure , regarding the definition, the caused, diagnosis, and management in cases of IVF
ICSI as it is presently performed is far from an ideal solution because the selection of sperm is based on the judgement of an embryologist, who is looking for the most normal appearing sperm available.
the objective is to clarify the problem of recurrent implantation failure , regarding the definition, the caused, diagnosis, and management in cases of IVF
Role of sperm index in embryo quality what to do - 17th iranian congressSandro Esteves
17th International Congress of the Iranian Association for Fertility and Reproductive Medicine
Tehran– March 2011
Abstract
ROLE OF SPERM INDEXES IN EMBRYO QUALITY: WHAT TO DO?
Sandro C. Esteves, MD, PhD
Spermatozoa are highly specializedcells with the purpose of not onlydelivering competent paternal DNA to the oocyte but also to provide a robust epigenetic contribution to embryogenesis. The identification of sperm fertility markers and the ability to selecthealthy spermatozoa for ART have a dual objective of choosing the best treatment strategy and optimizing ART outcomes. Currently, sperm indexes determination in the clinical setting is generally based on cell morphology and DNA content. Both sperm morphology and DNA integrity results, obtained from raw semen samples, have been shown to be of prognostic value for unassisted and assisted conception and useful in the selection of the best assisted conception modality.
These assays, however,provide an assessment of the distribution of cells in a given ejaculatethat may not be representative of the sperm population used in the ART treatment cycle. In fact, severe teratozoospermia,using Kruger’s strict criteria on pre-ART semen analysis, does notcorrelate to fertilization and embryo formation (including blastocyst development) in ICSI cycles. Nonetheless, if a more holistic approach to sperm morphology is taken, two prognostic groups can still be identified in cases of severeteratozoospermia (<4% normal) because certain morphology patterns and sperm abnormalities are known to affect ICSI outcomes. The first group includes mostly genetically determined sperm pattern defects, such asglobozoospermia, short tail syndrome and small-headed spermatozoa (in most cases combined with very small acrosomes). All of these types represent untreatable conditions that have been associated with abnormal sperm function andpoor ART outcomes. The second group includes unspecifiedor non-genetically determined sperm defects or patternscaused by environmental factors, medication, infection and related infertility conditions, including varicocele. Treatment of these conditions has been shown to optimize sperm morphology indexes with a positive impact on ART outcomes. Although the technician microscopically selects morphologically normal individual sperm during ICSI, form normalcy does not necessarily imply normal DNA content. As such, sperm DNA testing has been advocated to be an independent and reliable marker of fertility potential since sperm chromatin andDNA integrity is essential to ensure that the fertilizing sperm cansupport normal embryonic development of the zygote.At present, conflicting reports exist on the role of sperm DNA fragmentation index for embryo development, and it is apparent that DNA fragmentation does not significantly impair zygote and cleaving embryo morphology because major activation of the embryonic genome only beginafter the 4-cell stage. These observations do no underscore the importance of finding ways to increase sperm DNA integrity, since it has been suggested that DNA fragmentation is associated with late paternal effects that may lead to early miscarriages or diseases in the offspring. The etiology of sperm DNA damage is multi-factorial and may be due to primary (ageing, cryptorchidism, genetic defects, idiopathic) and or secondary (drugs, environmental, tobacco smoking, genital tract inflammation, infection,testicular hyperthermia and varicoceles) factors. Specific or non-specific treatments, including antioxidant supplements, are generally associated with reduced levels of sperm DNA damage and/or improved fertility potential.
Taken in conjunction, it is apparent that there is no unique sperm factor able to predict embryo development, but several candidate biomarkers are involved in this complex process.As a result, a wide variety of techniques have been proposed, including externalization of phosphotidylserine (magnetic-activated cell sorting),cell
Clinical management of men with nonobstructive azoospermia - Role of IVF Labo...Sandro Esteves
Reproductive Andrology Workshop III
17-21 January 2016 - Kuwait City - KUWAIT
Organized by: Al Jahra Reproductive Medicine Unit - Ministry of Health
Lecture 5: Role of IVF Laboratory in Nonobstructive Azoospermia
Air quality: is it that important? And if so, how to measure and control it?Sandro Esteves
Quality and Risk Management in the IVF Laboratory; Redlara Brasil, Belo Horizonte, 14-15 September 2016
Content:
1.Air quality: is it that important?
2. How to control?
3. How to measure?
Novel concepts in male factor infertility: clinical and laboratory perspectivesSandro Esteves
Presentation Objectives:
1. Update on the WHO reference values for semen parameters, and understand the role of sperm DNA fragmentation testing to decision-making strategies;
2. Learn how to counsel azoospermic men seeking fertility, and the role of gonadotropin therapy in this infertility condition;
3. Understand the benefits of microsurgery to both sperm retrieval and varicocele treatment;
4. Appraise the role of medical and surgical interventions to infertile men undergoing ART.
Public lecture - Stem Cell and Male InfertilitySandro Esteves
Reproductive Andrology Workshop III
17-21 January 2016 - Kuwait City - KUWAIT
Organized by: Al Jahra Reproductive Medicine Unit - Ministry of Health
Public Lecture - Stem Cell and Male Infertility
Clinical management of men with nonobstructive azoospermia - Sperm Retrieval ...Sandro Esteves
Reproductive Andrology Workshop III
17-21 January 2016 - Kuwait City - KUWAIT
Organized by: Al Jahra Reproductive Medicine Unit - Ministry of Health
Lecture 4: Sperm Retrieval Methods in Nonobstructive Azoospermia
Clinical management of men with nonobstructive azoospermia - Steps Before Spe...Sandro Esteves
Reproductive Andrology Workshop III
17-21 January 2016 - Kuwait City - KUWAIT
Organized by: Al Jahra Reproductive Medicine Unit - Ministry of Health
Lecture 3: Steps Before Sperm Retrieval in Nonobstructive Azoospermia
Clinical management of men with nonobstructive azoospermia - Chances of Harve...Sandro Esteves
Reproductive Andrology Workshop III
17-21 January 2016 - Kuwait City - KUWAIT
Organized by: Al Jahra Reproductive Medicine Unit - Ministry of Health
Lecture 2: Chances of Harvesting Sperm in Nonobstructive Azoospermia
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Sperm DNA Fragmentation from the Male Infertility Specialist's Perspective
1. Sandro C. Esteves, MD., PhD.
Director, ANDROFERT
Campinas, Brazil
Sperm DNA Fragmentation from
a Male Infertility Specialist’s
Perspective
Centre for Reproductive Health, Daresbury, United Kingdom
July 2014
2. Contents
Relationship between SDF and infertility
Methods for SDF assessment
Management Strategies
Esteves, 2 ANDROFERT, Referral Center for Male Reproduction
4. New WHO Reference Values
Caution to Interpret Results
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 4
2014 APRIL
ANDROFERT
5. Volume (mL)
1.5
Sperm count (x106/mL)
15.0
Total count (x106)
39.0
% Motile (total)
40
% Motile (progressive)
32
% Normal (strict criteria)
4
%Alive
58
Cooper et al. Hum Reprod Update 2010
WHO 2010: Recent fathers TTP ≤ 1 year
Percentiles
5% 50%*
95%
3.7
6.8
73.0
213.0
255.0
802.0
61
78
55
72
15
44
79
91
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 5
2014 APRIL
ANDROFERT
6. Esteves, 6 ANDROFERT, Referral Center for Male Reproduction
Why semen analysis is not enough
8. Lesions Associated with Sperm DNA
Damage
single-strand
break mis-match
damaged base
double-strand
break inter-strand
crosslink
intra-strand
crosslink
Defects in DNA structure:
Single-strand DNA break (ss-DB)
Double-strand DNA break (ds-DB)
Base deletion or modification
Inter or intra-strand cross linkage
Esteves, 8 ANDROFERT, Referral Center for Male Reproduction
Esteves et al 2013; Alvarez and Gosálbez 2011; Ward 2011
9. Biological Mechanisms of SDF
Protamination Failure
Replacement of histone to protamines during
spermiogenesis
Oxidative Stress
Epididymis transit
Post-ejaculation: leukocytes, immature sperm,
abnormal levels seminal plasma antioxidants
Apoptosis
During sperm maturation (testis & epididymis)
Fernández et al. 2009; Alvarez and Sakkas 2010; Agarwal et al. 2013
Esteves, 9 ANDROFERT, Referral Center for Male Reproduction
10. Environmental factors
Phtalate exposure, radiation,
temperature
Diseases
Varicocele, GTI, fever
Life-style
Obesity, smoking
Aging
External factors leading to
increased SDF
Kort et al. 2006; Rubes et al 2007; Viloria et al 2007; Esteves & Agarwal 2011
Esteves, 10 ANDROFERT, Referral Center for Male Reproduction
DNA Damage
11. SDF in Different Male Infertility
Etiologies
Esteves, 11 ANDROFERT, Referral Center for Male Reproduction
Gosálbez et al. 2013
12. Frequency of Elevated SDF in Men with
Normal Semen Analysis (WHO 2010)
Esteves, 12 ANDROFERT, Referral Center for Male Reproduction
36%
Androfert 2013; N=860; SCD test;
cutoff value of 20%
13. SDF and Infertility: Why bother?
Esteves, 13 ANDROFERT, Referral Center for Male Reproduction
Esteves et al. Int Urol Nehrol 2014
14. 19%
1.5%
Normal Elevated
Live Birth Rates with
Intrauterine Insemination
OR = 0.07
[95% CI: 0.01-0.48]
Bungum et al. Hum Reprod 2007
IUI Outcome and SDF
Esteves, 14 ANDROFERT, Referral Center for Male Reproduction
15. 26%
42%
IVF ICSI
Pregnancy by Method in
Cases of Elevated Sperm DNA
Fragmentation
IVF Outcome and SDF
Robinson et al. Hum Reprod 2012
Meta-analysis of 16 studies
and 2,969 couples
Increased miscarriage in
couples undergoing IVF/ICSI
with high SDF
Risk ratio (RR) = 2.16
95% CI: 1.54-3.03;
p<0.00001Bungum et al. Hum Reprod 2007
Esteves, 15 ANDROFERT, Referral Center for Male Reproduction
16. SDF and Reproductive Outcome
Points to consider (1)
Oocyte repair capability and severity
of damage
Menezo et al 2007; Genescá et al. 1992; Obe et al. 2002
Esteves, 16 ANDROFERT, Referral Center for Male Reproduction
• Repair likely to occur at pronuclei stage (prior
syngamy)
• Low levels breaks can be repaired (especially ss-DBs)
• Repair ability decrease with female age
17. Esteves, 17 ANDROFERT, Referral Center for Male Reproduction
Coding DNA (exons)
represent ~3% of genome
Esteves et al. 2014; Dada et al. 2012
SDF and Reproductive Outcome
Points to consider (2)
Site of damage
18. Viable pregnancies can be obtained in
cases of high SDF but…
l SDF is promutagenic
mutations could rise after fertilization as the
oocyte attempts to repair damage before
first cleavage
l Mutations will be fixed in the germline
associated with infertility, childhood cancer
in the offspring and for a higher risk of
imprinting diseases
Pang MG et al Hum Reprod 2005
Burrello et al Cytogenet Genome Res 2005.
Esteves, 18 ANDROFERT, Referral Center for Male Reproduction
19. Relationship between SDF and Infertiity
Key Messages
SDF
gives
different
informa4on
than
rou4ne
semen
analysis,
and
of
be;er
prognos4c
value
SDF
is
mainly
oxida4ve
stress-‐mediated
during
sperm
transit
through
the
epididymis
Esteves,
19
ANDROFERT,
Referral
Center
for
Male
Reproduc4on
Elevated
SDF
associated
with
infer4lity,
poor
ART
outcome
and
miscarriage
Reproduc4ve
outcome
related
to
oocyte
repair
capacity
as
well
as
severity
and
site
of
DNA
damage
20. Methods of SDF Assessment
Direct
Incorporation of probes at the site of damage
e.g. TUNEL, ISNT
Indirect
Susceptibility of DsDNA to denature in a acid solution
e.g. Sperm chromatin structure assay (SCSA), sperm
chromatin dispersion test (SCD), Comet assay
Chromatin compaction
Incorporation of probes to nuclear proteins
e.g. Aniline blue, toluidine blue
Gosálbez et al 2013; Esteves & Agarwal 2011; Esteves et al. 2013
Esteves, 20 ANDROFERT, Referral Center for Male Reproduction
21. Which is the best method for SDF?
Labor-
intensive
Expensive
equipment
Analysis
Subjectivity
Validation
& Standardization
TUNEL ++++ +++ ++ ++
SCSA ++ ++++ + ++++
Comet ++++ ++ +++ ++
SCD + + ++ +++
Esteves, 21 ANDROFERT, Referral Center for Male Reproduction
Esteves et al. Int Urol Nehrol 2014
22. Fertility and Sterility 2014; 101(1):58-63.
Esteves, 22 ANDROFERT, Referral Center for Male Reproduction
Comparison Between SDF Methods
23. Fernández et al. 2003, 2005; Gosálvez et al. 2006
Esteves, 23 ANDROFERT, Referral Center for Male Reproduction
Sperm Chromatin Dispersion (SCD)
Susceptibility of DNA to denaturation
with formation of single-strand (ss)
DNA from pre-existing single or
double strand breaks;
Difference in the pattern of forming a
loop (halo) around lysed and acid
treated nuclear membrane carcass
reflects the overall chromatin structure.
Combination of DNA denaturation used
in SCSA and protein depletion used in
the comet assay;
24. Enzymatic addition of modified
nucleotides to DNA breaks;
Sharma et al. 2010
Esteves, 24 ANDROFERT, Referral Center for Male Reproduction
TUNEL
Terminal deoxynucleotidyl transferase dUTP
nick end labeling
25. Correlation between SCD and TUNEL
Esteves, 25 ANDROFERT, Referral Center for Male Reproduction
• SCD more sensitive than
TUNEL
• Important to distinguish
between the methods as they
differently evaluate SDF
20.6
11.5
% SDF
SCD TUNEL
Fertil Steril 2014; 101(1):58-63.
P<0.01
26. Several
methods
available
to
assess
SDF
Methods
differen4ally
assess
SDF
and
cannot
determine
nature
or
e4ology
of
damage
Esteves,
26
ANDROFERT,
Referral
Center
for
Male
Reproduc4on
Best
method
yet
to
be
determined
Standardiza4on
and
EQC
is
needed
Key Messages (2)
27. What can we do about SDF?
• Antioxidants and life-style changes
• Avoid iatrogenic SDF during lab sperm
handling
Esteves, 27 ANDROFERT, Referral Center for Male Reproduction
• Treatment of underlying condition
Wong et al., 2000; Wong et al. 2002; Comhaire and Mahmoud, 2003; Agarwal and Said, 2004;
Bansal and Bilaspuri, 2010; Gosálbez et al. 2009, 2011; Esteves et al. 2011; Sánchez-Martín et al 2013
• Short abstinence period
• Sperm selection techniques
28. Outcome
No.
studies
Effect
size
(OR;
95%
CI)
Live
birth
3
4.85
[1.92,
12.24]
Pregnancy
rate
15
4.18
[2.65,
6.59]
DNA
fragmenta4on
1
-‐13.80
[-‐17.50,
-‐10.10]
Miscarriage,
sperm
count,
sperm
mo4lity
6-‐16
No
effect
Oral Antioxidants
Showell MG et al. Cochrane Database Syst Rev 2011
Esteves, 28 ANDROFERT, Referral Center for Male Reproduction
29. Oral Antioxidants
l Short-term use
appear to be safe
l Caution against
indiscriminate
use of high
dosages for long
periods
Beneficial
Kodama 1997
Dawson, 1992
Kessopoulou, 1995
Vezina, 1996
Vicari, 2001; 2002
Lenzi, 2003; 2004
Cavallini, 2004
Comhaire, 2005
Grecco 2005
Menezo 2007
Tremellen 2007
Piomboni 2008
Gil Villa 2009
No effect
Giovenco, 1987
Moilanen, 1993
Iwanier, 1995
Rolf, 1999
Sigman, 2006
Detrimental
long-term use and high
doses;
increased mortality in
cancer population-
based studies.
Heinonen, 1994
Lonn, 2005
Bjelakovic, 2007
Esteves, 29 ANDROFERT, Referral Center for Male Reproduction
30. Oral Antioxidants
How I prescribe
Vitamin C 500mg; Vitamin E 400 mg
Folic acid 2 mg, Zinc 25 mg
Selenium 26 mcg
Minimum 2 months
Old concept ~80 days
New concept ~60 days
From initiation of sperm production to ejaculation
Misell LM et al. J Urol. 2006
Esteves & Agarwal. Novel concepts in male infertility. Int Braz J Urol 2011
Esteves, 30 ANDROFERT, Referral Center for Male Reproduction
31. Henkel R et al, AJA 2007; Alvarez et al. Fertil Steril 2002
25%
34%
39%
Normal Abnormal Abnl &
Leukocytospermia
% DNA Damage (SCSA)
Esteves, 31 ANDROFERT, Referral Center for Male Reproduction
Decrease No. Leukocytes in Semen
granulocyte macrophage lymphocyte
Endtz
test
32. Anti-bacterial
properties (Zinc)
Subclinical Male Genital Tract Infection
Azitromycin 1.0g single dose (couple)+ frequent
ejaculation (every 2-3 days) + Antioxidants:
• 42% leukocytospermia resolution (N=278)
Esteves, 32 ANDROFERT, Referral Center for Male Reproduction
33. Miyaoka & Esteves. Adv Urol 2012
Agarwal, Esteves, Hamada. Nature Urol Rev 2013;
Wang YJ et al. Reprod Biomed Online. 2012.
Esteves, 33 ANDROFERT, Referral Center for Male Reproduction
Varicocele
Twelve studies comparing
SDF in pts. with and
without varicocele:
SDF higher in varicocele
Mean difference = 9.9%
(95% CI: 9.2-10.5; p<0.0001)
36. Wang YJ et al.
Reprod Biomed Online. 2012;25:307-14.
Seven studies evaluating
the effect of varicocele
repair
SDF decreased after repair
Mean difference = 3.4%
(95% CI: -4.1 to -2.6;
p<0.0001)
Esteves, 36 ANDROFERT, Referral Center for Male Reproduction
Effect of Varicocele Surgery on SDF
38. Sperm % TUNEL + % CPR
Ejaculated 23.6 6
Testicular 4.8 44
P value <0.001 <0.05
Greco et al. Hum Reprod 2005
TESA-ICSI and SDF
Esteves, 38 ANDROFERT, Referral Center for Male Reproduction
39. SDF three-
fold lower in
testicular
sperm*
*Absolute differences between two specimens ranging from -3.3% to -56.3%.
Moskovtsev et al. Fertil Steril 2010
Esteves, 39 ANDROFERT, Referral Center for Male Reproduction
Difference in SDF between
Testicle and Ejaculate
41. Abstinence Period
Esteves, 41 ANDROFERT, Referral Center for Male Reproduction
Gosálbez et al. Fertil Steril 2011
Serial ejaculation every 24h
for 4 days: 25% reduction SDF
42. Sperm Processing by DGC
Esteves, 42 ANDROFERT, Referral Center for Male Reproduction
Gosálbez et al. Fertil Steril 2011
Density gradient
centrifugation: 22%-44%
reduction in SDF
43. Dynamic Nature of SDF
Iatrogenic damage
Esteves, 43 ANDROFERT, Referral Center for Male Reproduction
44. Zeta method
Modified HOST
IMSI
PICSI
Sperm head
birefringence
Electrophoretic
selection
Magnetic- activated
cell sorting
Sperm Selection Techniques & SDF
Esteves, 44 ANDROFERT, Referral Center for Male Reproduction
45. Current non-invasive sperm
selection techniques are limited
in their ability to select
chromatin-intact spermatozoa
None of the available techniques
can directly assess sperm DNA
fragmentation
Dyes are needed to reach the
nucleus, using fixed specimens
Sperm Selection Techniques & SDF
Esteves, 45 ANDROFERT, Referral Center for Male Reproduction
46. SDF and Embryo Quality
Reference Assay N ART Findings
Larson et al., 2000 SCSA 24 IVF; ICSI No impact (D3)
Gandini et al., 2004 SCSA 34 IVF; ICSI No impact (D3)
Payne et al., 2006 SCSA 100 IVF; ICSI No impact (D3)
Sun et al., 1997 TUNEL 236 IVF ↓ Cleavage (D3)
Morris et al., 2002 Comet 60 ICSI ↓ Cleavage;
Morphology (D3)
Virro et al., 2004 SCSA 249 IVF; ICSI ↓ Blastulation rate
Nasr-Esfahani et al., 2005 Comet,
CMA3
28 ICSI ↓ Blastocyst
development
Esteves, 46 ANDROFERT, Referral Center for Male Reproduction
47. Oral antioxidants, life-style
modifications (quit smoking,
weight loss)
Esteves,
47
ANDROFERT,
Referral
Center
for
Male
Reproduc4on
TESA-ICSI for men with high
SDF enrolled in ART
Identify and treat underlying
condition such as GTI and
clinical varicocele
Management Strategies: Clinical
Key Messages
48. Short abstinence (1 day) and
frequent ejaculation
Esteves,
48
ANDROFERT,
Referral
Center
for
Male
Reproduc4on
Post-processing incubation
should not exceed 4h
Sperm processing by DGC
Management Strategies: Laboratory
Key Messages